NPC Ventures is a $50-million investment fund for early-stage Canadian companies developing naturally-derived alternatives to synthetic products. The fund is led by Kristi Miller, who says she believes there exists a “tremendous opportunity for Canadian companies to meet this exponential demand for ‘natural’.”
Topic: Venture Capital
The Short Report – March 17, 2021: Canadian government invests heavily to bolster biomanufacturing, D-Wave Systems gets funding for quantum tech, Canada’s largest study on aging gets a top-up, and more
The Government of Canada seeks to bolster Canada’s biomanufacturing capacity, D-Wave receives $40 million to accelerate Canada’s quantum technology development, the federal government invests in Canada’s longest-ever study on aging, Quebec’s Lion Electric gets ready to break ground on a new battery manufacturing plant, and more.
The Short Report – Oct. 28, 2020: UWaterloo targets Japanese market, Calgary breaking venture capital record, and more
Genome research receives major funding related to health, agriculture and environmental projects while Canadian Nuclear Labs pursue clean energy technologies for marine operations in Canada and internationally.
Opinion: Strengthening Black entrepreneurship will boost our economy’s potential. Here’s why.
Despite its progressive image, the tech startup world is by no means immune to the problem of systemic racism. We must call on both public and private sectors to support underrepresented entrepreneurs as an explicit part of our action plan for economic recovery.
How a new generation of engineers-turned-investors is shaping Canadian tech
In the last several years, Canada has emerged as one of the top tech ecosystems in the world. A new crop of founders exiting companies and moving into investing is helping to drive the uptick in Canadian innovation.
Q&A: BDC Capital shares the philosophy and strategy behind its new $160-million IP fund
In July, BDC Capital announced that it is committing $160 million to finance intellectual property (IP) development in Canada with the hopes to fill the gap in capital financing for scaling companies with intangible assets. We spoke with Patrick Latou about what they plan to achieve and why this type of fund is so overdue.
Alberta agri-food sector gets a boost with launch of new research and innovation network
A new $108.5-million technology and agri-food research and innovation network, supported by the federal government and industry, is expected to begin operations by the end of this month. Alberta Innovates’ Inventures conference also highlighted a new $40 funding challenge from Emissions Reduction Alberta to accelerate technology innovation in agriculture, agri-food and forestry.
The Short Report, May 13, 2020: Public trust in science rising; new COVID-19 advisory councils created; OneEleven ceases operations; and more
COVID-19 NEWS Canadians’ trust in doctors, scientists and the government has increased since the cornovirus pandemic began, finds public opinion polls from January and repeated on May 1 and May 2. Conducted by Proof Strategies CanTrust Index of Ottawa, the survey found that 76% of Canadians trusted doctors and 70% trusted scientists. The follow up…
The Short Report, May 6, 2020: AbCellera receives $175.6M for COVID-19 therapies; Canada contributes $850 million to global pandemic response; new “super angel” fund launches; and more
Vancouver-based AbCellera Biologics will receive up to $175.6 million from the federal Strategic Innovation Fund to fast-track antibody therapies against COVID-19. The funding will also go to build a first-of-its-kind antibody manufacturing facility over the next four years to help Canada respond to future pandemics. AbCellera has partnered with global biopharmaceutical company Eli Lilly to…
Vancouver biotech firm AbCellera wins SIF research funding to fast-track antibody therapies against COVID-19
Vancouver-based biotech firm AbCellera, using its technology spun off research at University of British Columbia, is fast-tracking testing and clinical trials of therapeutic antibodies against COVID-19.